216 related articles for article (PubMed ID: 19714336)
1. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.
Erbersdobler A; Isbarn H; Dix K; Steiner I; Schlomm T; Mirlacher M; Sauter G; Haese A
World J Urol; 2010 Dec; 28(6):687-92. PubMed ID: 19714336
[TBL] [Abstract][Full Text] [Related]
2. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
3. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.
Rubin MA; Buyyounouski M; Bagiella E; Sharir S; Neugut A; Benson M; de la Taille A; Katz AE; Olsson CA; Ennis RD
Urology; 1999 Mar; 53(3):542-7. PubMed ID: 10096381
[TBL] [Abstract][Full Text] [Related]
4. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31.
de la Taille A; Katz AE; Bagiella E; Buttyan R; Sharir S; Olsson CA; Burchardt T; Ennis RD; Rubin MA
Am J Clin Pathol; 2000 Apr; 113(4):555-62. PubMed ID: 10761458
[TBL] [Abstract][Full Text] [Related]
5. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate.
Silberman MA; Partin AW; Veltri RW; Epstein JI
Cancer; 1997 Feb; 79(4):772-9. PubMed ID: 9024715
[TBL] [Abstract][Full Text] [Related]
6. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
Bettencourt MC; Bauer JJ; Sesterhenn IA; Connelly RR; Moul JW
J Urol; 1998 Aug; 160(2):459-65. PubMed ID: 9679898
[TBL] [Abstract][Full Text] [Related]
7. Microvessel density in prostate carcinoma.
Bono AV; Celato N; Cova V; Salvadore M; Chinetti S; Novario R
Prostate Cancer Prostatic Dis; 2002; 5(2):123-7. PubMed ID: 12497001
[TBL] [Abstract][Full Text] [Related]
8. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer.
Strohmeyer D; Rössing C; Strauss F; Bauerfeind A; Kaufmann O; Loening S
Prostate; 2000 Jan; 42(1):26-33. PubMed ID: 10579796
[TBL] [Abstract][Full Text] [Related]
9. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?
Schlemmer HP; Merkle J; Grobholz R; Jaeger T; Michel MS; Werner A; Rabe J; van Kaick G
Eur Radiol; 2004 Feb; 14(2):309-17. PubMed ID: 14531000
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
[TBL] [Abstract][Full Text] [Related]
11. Independent prognostic importance of microvessel density in clinically localized prostate cancer.
Halvorsen OJ; Haukaas S; Høisaeter PA; Akslen LA
Anticancer Res; 2000; 20(5C):3791-9. PubMed ID: 11268456
[TBL] [Abstract][Full Text] [Related]
12. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate.
Krupski T; Petroni GR; Frierson HF; Theodorescu JU
Urology; 2000 May; 55(5):743-9. PubMed ID: 10792093
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays.
Tretiakova M; Antic T; Binder D; Kocherginsky M; Liao C; Taxy JB; Oto A
Hum Pathol; 2013 Apr; 44(4):495-502. PubMed ID: 23069258
[TBL] [Abstract][Full Text] [Related]
14. Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease.
Di Lorenzo G; De Placido S; Autorino R; De Laurentiis M; Mignogna C; D'Armiento M; Tortora G; De Rosa G; D'Armiento M; De Sio M; Bianco AR; D'Armiento FP
Prostate Cancer Prostatic Dis; 2005; 8(1):54-9. PubMed ID: 15655565
[TBL] [Abstract][Full Text] [Related]
15. Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.
Revelos K; Petraki C; Scorilas A; Stefanakis S; Malovrouvas D; Alevizopoulos N; Kanellis G; Halapas A; Koutsilieris M
Anticancer Res; 2007; 27(5B):3651-60. PubMed ID: 17972531
[TBL] [Abstract][Full Text] [Related]
16. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of vasohibin-1 expression in patients with prostate cancer.
Kosaka T; Miyazaki Y; Miyajima A; Mikami S; Hayashi Y; Tanaka N; Nagata H; Kikuchi E; Nakagawa K; Okada Y; Sato Y; Oya M
Br J Cancer; 2013 May; 108(10):2123-9. PubMed ID: 23591203
[TBL] [Abstract][Full Text] [Related]
18. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
[TBL] [Abstract][Full Text] [Related]
19. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
Martinović Ž; Kovač D; Martinović C
World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer.
Offersen BV; Borre M; Overgaard J
APMIS; 1998 Apr; 106(4):463-9. PubMed ID: 9637268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
